BioMedTracker is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Informa

Search

Drug Impact Events

Date Lead
Company
Event Type Approval
Change
Approval
Likelihood
5/5/16 GlaxoSmithKline (GSK) IONIS-TTRrx for Transthyretin Amyloid (ATTR) Cardiomyopathy (Familial Amyloidotic Cardiomyopathy) Subscribers Only Subscribers Only Subscribers Only
5/5/16 Eisai (ESALY) Halaven for Sarcoma Subscribers Only Subscribers Only Subscribers Only
5/5/16 Fortress (FBIO) MB-101 for Brain Cancer (malignant glioma; AA and GBM) Subscribers Only Subscribers Only Subscribers Only
5/4/16 Applied Genetic Technologies (AGTC) rAAV1-CB-hAAT for Emphysema Subscribers Only Subscribers Only Subscribers Only
5/4/16 Sellas Galinpepimut-S for Mesothelioma Subscribers Only Subscribers Only Subscribers Only

Upcoming Catalysts

Expected
Date Range
Lead
Company
Drug Expected
Catalyst
05/06/16 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
05/06/16 Subscribers Only Subscribers Only Trial Data - Top-Line Results
05/06/16 Subscribers Only Subscribers Only Trial Data - Updated Results
05/06/16 Subscribers Only Subscribers Only Regulatory - PDUFA/Approval Decision (US)
05/06/16 Subscribers Only Subscribers Only Trial Data - Other